4 ms·
I dug into this a bit and while they are doing some testing, I’m not sure they really know what they are doing. When they originally flagged the NDMA issue in
by refurb 7y ago
I dug into this a bit and while they are doing some testing, I’m not sure they really know what they are doing.
When they originally flagged the NDMA issue in Zantac, they published their results. One of the tablets had 32,000 ppm of NDMA. That’s an absurdly high level that should have made them question the result.
Turns out they used a different testing procedure for a different set of drugs. The procedure required heating the sample to 80c for like an hour. The FDA came back and said “yeah, that’s not the right test”. Many drugs will decompose with heat and produce a bunch of impurities. Impurities that aren’t produced in the human body.
Testing for impurities is actually really hard as your testing procedure can have a big impact on the measurements.
Based on the latest FDA guidance, it sounds like Zantac does have higher than allowed NDMA levels, but nothing like what this lab suggests.
So I’d say they are offering a useful service, but they aren’t sophisticated enough to make a judgement call on.
- gus_massa 7y agoDo you have a link for the 80°C (176°F)? In that case the description in the article "emulated the stomach" is misleading at least. The 80°C (176°F) is more like sous vide cooking.
- refurb 7y agoIt may not have been that high, but I remember being surprised by how much higher than physiological temperature. The FDA is doing a great job keeping the public informed. https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-ndma-zantac-ranitidine https://www.fda.gov/drugs/drug-safety-and-availability/fda-u... Check out the 10/2 update with regards to temperature. Here is the relevant part: FDA observed the testing method used by a third-party laboratory uses higher temperatures. The higher temperatures generated very high levels of NDMA from ranitidine products because of the test procedure. FDA published the method for testing angiotensin II receptor blockers (ARBs) for nitrosamine impurities. That method is not suitable for testing ranitidine because heating the sample generates NDMA. To Valisure’s credit they are posting their data. https://www.valisure.com/wp-content/uploads/Attachment-B-GC-MS-Ranitidine-Data-Report_v6.2.pdf https://www.valisure.com/wp-content/uploads/Attachment-B-GC-... However, they are using GC/MS, which typically had pre-column temperatures of >150C (since all analyses need to be in the gas phase). Plenty of drugs decompose at those temperatures. That’s why the FDA doesn’t recommend it.
- heymijo 7y agoPosted a response to OP, but if you want to hear the pharmacy CEO discuss this testing in depth with Dr. Peter Attia, check out their podcast from a few weeks ago https://podcasts.apple.com/us/podcast/the-peter-attia-drive/id1400828889?mt=2 https://podcasts.apple.com/us/podcast/the-peter-attia-drive/... https://peterattiamd.com/davidlight/ https://peterattiamd.com/davidlight/
- gus_massa 7y agoThanks for the link. Some relevant quotes: > This means you heat the drug up to 130 degrees celsius for 15 minutes [130°C=266°F] That's more temperature than the 80°C in the GP comment. It's common that drugs decompose with temperature. --- > And tested again and found 300,000 nanograms of NDMA in one tablet of Zantac > SGF with 50mM Sodium Nitrite | 3,045 [ng/ml] | 304,500 [ng/tablet] [SGF = simulated gastric fluid, 37°C=98°F, I'd like to see the pH, let's assume 2 or something] The concentration of Sodium Nitrite is weird because it is like x500 bigger than the maximal allowed level in drinking water, and it is also like a hundred times the concentration you'd get from sausages.
- heymijo 7y agoYou're welcome! This stuff is way outside my area of expertise, but I'm obviously curious what the heck is going on. Glad to see this discussion here on HN.
- refurb 7y agoThanks for posting the podcast link. As I mentioned earlier, testing pharmaceuticals is not easy. Usually you need to develop a specific method for each drug and then validate it. It’s very easy to actually introduce an impurity (or the appearance of an impurity) with the wrong process. Ranitidine (Zantac) is even more challenging when it comes to NMDA. Most drugs have that impurity from the manufacturing process. Solvents and chemicals react to produce traces of it. Ranitidine has the building blocks of NMDA in the molecule itself. So decomposition of ranitidine will produce NMDA. You could start with 100% pure ranitidine and if you test it wrong, you’ll produce NMDA and be convinced it was in the original material when it wasn’t.
- satya71 7y agoThe same article says the level of NDMA is similar to that in barbecue meat. So much medicine recalled, and panic from major manufacturers (why didn't they test before panicking?), over a result that may not be even accurate in the first place.
- refurb 7y agoIt’s probably two reasons: 1) it’s a carcinogen and cancer risks make headlines and 2) it’s a risk that wasn’t there to begin with (unlike bbq meat which was known). That said, you are correct. Stacked up against all the risk you might face in life this isn’t that concerning.
- devnulloverflow 7y ago> why didn't they test before panicking? Because that's the sort of thing that can blow out a lawsuit or result in bad press.
- heymijo 7y agoThe testing issue is discussed thoroughly in the podcast interview Dr. Peter Attia did with David Light (Valisure CEO). While your interpretation seems to be that using the different test brings these wild results into question, this discussion seems to conclude that, yes, it's a different test, but no, the results are no less concerning. Take a listen for yourself! https://peterattiamd.com/davidlight/ https://peterattiamd.com/davidlight/ https://podcasts.apple.com/us/podcast/the-peter-attia-drive/id1400828889?mt=2 https://podcasts.apple.com/us/podcast/the-peter-attia-drive/...